| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/06/2009 | CA2347979C Treatment of skin with adenosine or adenosine analog |
| 01/06/2009 | CA2340921C Use of taxanes to treat brain cancer |
| 01/06/2009 | CA2340238C Improved stability for injection solutions |
| 01/06/2009 | CA2339174C Aminosterol compounds and uses thereof |
| 01/06/2009 | CA2333869C Mousse composition |
| 01/06/2009 | CA2309353C Surfactant-based antimicrobial compositions and methods for using same |
| 01/06/2009 | CA2308495C Anaesthetic formulation |
| 01/06/2009 | CA2308315C N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents |
| 01/06/2009 | CA2295446C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 01/06/2009 | CA2288533C New 4-substituted piperidines |
| 01/06/2009 | CA2264582C Sulfonyl fluorides for the treatment of alzheimer's disease |
| 01/06/2009 | CA2253364C Selection and/or enhancement of resident microorganisms in the gastrointestinal tract |
| 01/06/2009 | CA2245584C Recombinant expression of s-layer proteins |
| 01/06/2009 | CA2244512C Dietary supplements containing natural ingredients |
| 01/06/2009 | CA2235350C Use of creatine or creatine analogs for the treatment of diseases of the nervous system |
| 01/06/2009 | CA2227851C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 01/06/2009 | CA2216696C Polysaccharide-bound nitric oxide-nucleophile adducts |
| 01/06/2009 | CA2216546C 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity |
| 01/06/2009 | CA2213519C Suksdorfin analogs, compositions thereof, and methods for making and using thereof |
| 01/06/2009 | CA2194979C Solid drug forms containing clathrates of steroid sex hormones |
| 01/06/2009 | CA2177007C Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/06/2009 | CA2169219C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them |
| 01/06/2009 | CA2156216C Process for the esterification of a polyphenolic oligomer extract derived from plants, composition thus obtained and use thereof |
| 01/06/2009 | CA2149770C Detection of hypoxia |
| 01/06/2009 | CA2144406C Gene transcription and ionizing radiation: methods and compositions |
| 01/06/2009 | CA2120319C Pharmaceutical for the treatment of skin disorders |
| 01/06/2009 | CA2117490C Purified vacuolating toxin from helicobacter pylori and methods to use same |
| 01/06/2009 | CA2113819C Novel glycoside compounds and production and use thereof |
| 01/05/2009 | CA2636967A1 Patch and patch preparation |
| 01/05/2009 | CA2636965A1 Patch and patch preparation |
| 01/02/2009 | DE60224401T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure |
| 01/02/2009 | DE102007030434A1 Flüssige Lösungsvermittler enthaltend ethoxylierte Fettalkohole und ethoxylierte Triglyceride Liquid solubilizer containing ethoxylated fatty alcohols and ethoxylated triglycerides |
| 01/02/2009 | DE102007030370A1 Acetic acid-solvate of risedronate, useful e.g. to treat or prevent bone resorption disorder, tumors or a disturbed calcium- or phosphate-metabolism |
| 01/01/2009 | US20090007280 Ange gene in atopy |
| 01/01/2009 | US20090005849 Methods and apparatuses for coating a lesion |
| 01/01/2009 | US20090005763 Implantable Devices and Methods for Delivering Drugs and Other Substances to Treat Sinusitis and Other Disorders |
| 01/01/2009 | US20090005580 Compounds, compositions and methods |
| 01/01/2009 | US20090005568 Substituted 2-aminothiazoles for treating neurodegenerative diseases |
| 01/01/2009 | US20090005567 Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo (5,6)-cyclohepta-(1,2b) -pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester (loratadine) |
| 01/01/2009 | US20090005551 Coupling silylated 5-azacytosine to a protected ribofuranose using trimethylsilyl trifluoromethane catalyst; cooling, accumulation by filtration, quenching, solvent extraction |
| 01/01/2009 | US20090005461 Use of Cannabidiol in the Treatment of Hepatitis |
| 01/01/2009 | US20090005460 Methods of making and using structured compositions comprising betaine |
| 01/01/2009 | US20090005459 NMDA receptor antagonists and their use in inhibiting abnormal hyperphosphorylation of microtubule associated protein tau |
| 01/01/2009 | US20090005458 Preferably in sustained release dosage form; Side effect reduction compared to conventional analgesics |
| 01/01/2009 | US20090005457 Solid forms comprising (-)-O-desmethylvenlafaxine and uses thereof |
| 01/01/2009 | US20090005456 Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors |
| 01/01/2009 | US20090005455 (R,S)-1-[2-oxido-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-cyclohexanol (venlafaxine N-oxide); depression, major depressive disorder, generalized anxiety disorder, obsessive compulsive disorder, social anxiety disorder, panic disorder, general depressive disorders, diabetic neuropathy, migraine |
| 01/01/2009 | US20090005454 Method of Reducing Nosocomial Infections |
| 01/01/2009 | US20090005453 Crystalline forms of tigecycline and processes for preparation thereof |
| 01/01/2009 | US20090005452 Diphenyl Urea Derivatives |
| 01/01/2009 | US20090005451 Compounds for the treatment of metabolic disorders |
| 01/01/2009 | US20090005450 Use of creatine compounds for the treatment of eye disorders |
| 01/01/2009 | US20090005448 Injection for Mastitis |
| 01/01/2009 | US20090005447 Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism |
| 01/01/2009 | US20090005446 Prophylactic Antistress Agent |
| 01/01/2009 | US20090005445 Article comprising calcium for reducing the production of TSST-1 |
| 01/01/2009 | US20090005444 Use of propofol prodrugs for treating alcohol withdrawal, central pain, anxiety or pruritus |
| 01/01/2009 | US20090005443 Treatment of Depression |
| 01/01/2009 | US20090005442 Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 01/01/2009 | US20090005441 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
| 01/01/2009 | US20090005440 Pharmaceutical composition and health food comprising extract of phellinus sp.pl 3 or phellinsin a isolated from the same as an effective component for prevention and treatment of cardiovascular disease |
| 01/01/2009 | US20090005439 Mixture of organic peroxide such as benzoyl peroxide and antioxidant such as butylated hydroxyltoluene; shelf life, storage stability; skin disorders, acne agents; cosmetics |
| 01/01/2009 | US20090005438 Use of Isothiocyanates Compounds in Treating Prostatic Diseases and Skin Cancer |
| 01/01/2009 | US20090005437 Alpha-Ketoglutarates and Their Use as Therapeutic Agents |
| 01/01/2009 | US20090005436 Substituted Aminoalkyl- and Amidoalkyl-Benzopyran Derivatives |
| 01/01/2009 | US20090005435 Novel Compounds, Pharmaceutical Compositions Containing Same, and Methods of Use for Same |
| 01/01/2009 | US20090005434 Novel Salicylic Anilides |
| 01/01/2009 | US20090005433 Fluorinated Compounds |
| 01/01/2009 | US20090005432 Pharmaceutical compositions including low dosages of desmopressin |
| 01/01/2009 | US20090005431 Substituted pyrrolidines |
| 01/01/2009 | US20090005430 Receptor Blocker and Vasodilator Comprising Indole Derivative as Active Ingredient |
| 01/01/2009 | US20090005429 Process for the preparation of carvedilol and its enantiomers |
| 01/01/2009 | US20090005428 Imidazole Derivatives for the Treatment of Gastrointestinal Disorders |
| 01/01/2009 | US20090005427 Substituted oxadiazole compounds and their use as opioid receptor ligands |
| 01/01/2009 | US20090005426 Pharmaceutically active sulfonyl hydrazide derivatives |
| 01/01/2009 | US20090005425 Complex Formulation Comprising Amlodipine Camsylate And Simvastatin and Method For Preparation Thereof |
| 01/01/2009 | US20090005424 Composition and Method for Treating Fibrotic Diseases |
| 01/01/2009 | US20090005423 Systems and methods for effecting cessation of tobacco use |
| 01/01/2009 | US20090005422 Bacterial thioredoxin reductase inhibitors and methods for use thereof |
| 01/01/2009 | US20090005421 Novel Pyridine Derivatives |
| 01/01/2009 | US20090005420 Inhibitors of Matrix Metallaproteinases |
| 01/01/2009 | US20090005419 Organic Compounds |
| 01/01/2009 | US20090005418 such as 2-benzyl-5-(2,5-difluorophenyl)-3-phenyl-2,3-dihydroisoxazole, useful for treating cellular proliferative diseases such as cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation in mammals |
| 01/01/2009 | US20090005417 Substituted Indazolyl Sulfonamide and 2,3-Dihydro-Indolyl Sulfonamide Compounds, their Preparation and Use in Medicaments |
| 01/01/2009 | US20090005416 Benzimidazole derivatives |
| 01/01/2009 | US20090005415 1,2-Diarylimidazoles for Use as Cb1 Modulators |
| 01/01/2009 | US20090005414 Polymorph of N,N-Diethyl-4-(3-Fluorophenyl-Piperidin-4-Ylidene-Methyl)-Benzamide Hydrochloride Salt |
| 01/01/2009 | US20090005413 Novel Salt of Montelukast |
| 01/01/2009 | US20090005412 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/01/2009 | US20090005411 Combinations of Organic Compounds |
| 01/01/2009 | US20090005410 N-(4-Chloro-2-[1,2,3]triazolo[4,5-b]pyridin-1-yl-phenyl)-4-(1-hydroxy-1-methyl-ethyl)-benzene-sulfonamide sodium salt, used as chemokine receptors antagonists, useful for treating inflammation |
| 01/01/2009 | US20090005409 Pyrrolo[3,2-C] Pyrdine Derivatives and Processes for the Preparation Thereof |
| 01/01/2009 | US20090005408 Process for the production of an abuse-proofed dosage form |
| 01/01/2009 | US20090005407 Particulate (3'-chlorobiphenyl-4-yl)(1-(pyrimidin-2-yl)piperidin-4-yl)methanone and methods of its use |
| 01/01/2009 | US20090005406 Cancer Treatment Method |
| 01/01/2009 | US20090005405 Compositions and methods for treating and preventing dermatoses |
| 01/01/2009 | US20090005404 Pyridylsulfonamido pyrimidines for treating diabetic nephropathy |
| 01/01/2009 | US20090005402 Medicine containing pyrimidine derivative |
| 01/01/2009 | US20090005401 Novel Compounds |
| 01/01/2009 | US20090005400 Biologically Active Aphrocallistin Compounds |